The News Review:

- … Medical Appoints Dr. Marwan Sabbagh Director of Clinical…
- American Cancer Society To Present Highest Honor For utstanding…
- Q3 2007 Nastech Pharmaceutical Earnings Conference Call – Final.
- Clinical Trials Prove Med-Tech Systems International’s Air…

… Medical Appoints Dr. Marwan Sabbagh Director of Clinical…
Free with registration – Business Wire – AccessMyLibrary.com – Oct 29, 2007
Sabbagh a national leader in neurodegenerative disease will collaborate with Power3 Medical in a validation study of blood serum patient samples using Power3′s NuroPro[R] diagnostic screening test. Sabbagh is currently the Director of Clinical Research at the Cleo Roberts Center of Clinical Research at the Sun. CPYRIGHT 2007 Business Wire… Sabbagh a national leader in neurodegenerative disease will collaborate with Power3 Medical in a validation study of blood serum patient samples using Power3′s NuroPro[R] diagnostic screening test. Sabbagh is currently the Director of Clinical Research at the Cleo Roberts Center of Clinical Research at the Sun. CPYRIGHT 2007 Business Wire.

American Cancer Society To Present Highest Honor For utstanding…
Medical News Today – Medical News Today (press release) – Oct 29, 2007
The Medal of Honor originally called the American Cancer Society Award was first given in 1949. Myers president and chief executive officer of the Campaign for Tobacco-Free Kids will receive the Society’s Medal of Honor for Cancer Control. He is being honored for his relentless work to eliminate tobacco use among children. By changing public attitudes and public policies on tobacco the Campaign for Tobacco-Free Kids which is a leader in the fight to reduce tobacco use in the US and around the globe strives to prevent kids from smoking help smokers quit and protect everyone from secondhand smoke. The Campaign also acts as a counter force to the tobacco industry and its special interests.

Q3 2007 Nastech Pharmaceutical Earnings Conference Call – Final.
Free with registration – Fair Disclosure Wire – AccessMyLibrary.com – Oct 29, 2007
Rick’s presence at Nastech and his prior leadership role will ensure continuity in our research and development programs. Now I would like to turn the call over to Gordon for a discussion of our current clinical and regulatory programs. GRDN BRANDT EVP CLINICAL RESEARCH & MEDICAL AFFAIRS NASTECH PHARMACEUTICAL: Thanks Steve. Let me begin with discussion with our PTH nasal spray program. As previously mentioned P&G continues to work on the Phase II development program and we’re helping them evaluate available biomarker data and then determine the appropriate next steps in the clinical program for PTH nasal spray for osteoporosis. The market for PTH treatment continues to expand. The injected form of PTH recorded annualized sales of $720 million on a 21% increase year-over-year in the most recent fiscal quarter for Lily.

Clinical Trials Prove Med-Tech Systems International’s Air…
Free with registration – Business Wire – AccessMyLibrary.com – Oct 29, 2007
Clinical Trials Prove Med-Tech Systems International’s Air Sterilization Device Dramatically Reduces Symptoms of Respiratory Illnesses. (29-CT-07) Business Wire.